Risk Management for Central Line-associated Bloodstream Infection in ICU
To assess the epidemiological characteristics, disease burden, clinical impacts, risk factors, prediction model, and the effectiveness and safety of interventions have been taken clinically for CLABSI.
Grant dates
Monday, January 1, 2024 to Thursday, December 31, 2026
Amount
$50,000
Related program
Health Policy and Systems Sciences
Region
China
Grant number
23-524
Year
2023
Principal Investigator
Shichao ZHU